Fonar (FONR) P/E (2011 - 2026)
Fonar (FONR) P/E from Sep 30, 2011 to Jun 5, 2026. The TTM Fonar (FONR) P/E is 15.47. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Fonar (FONR)
| Year | P/E | Change |
|---|---|---|
| 2026 | 15.47 | +6.29% |
| 2025 | 14.56 | +56.56% |
| 2024 | 9.30 | -10.07% |
| 2023 | 10.34 | +15.40% |
| 2022 | 8.96 | +36.27% |
| 2021 | 6.57 | -41.42% |
| 2020 | 11.22 | +23.10% |
| 2019 | 9.12 | +3.69% |
| 2018 | 8.79 | +1.90% |
| 2017 | 8.63 | -3.94% |
| 2016 | 8.98 | -5.12% |
| 2015 | 9.47 | +36.98% |
| 2014 | 6.91 | -62.01% |
| 2013 | 18.20 | +296.19% |
| 2012 | 4.59 | -29.78% |
| 2011 | 6.54 | N/A |
Comparison Fonar (FONR) P/E with competitors
Fonar (FONR) P/E is 15.47.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| ADVB | Advanced Biomed Inc | 1.05 | -93.22% |
| MBAI | CheckCap Ltd | 1.71 | -88.93% |
| QGEN | Qiagen NV | 20.03 | +29.45% |
| DGX | Quest Diagnostics Inc | 22.47 | +45.25% |
| LH | Laboratory Corp Of America Holdings | 23.87 | +54.28% |
| IQV | IQVIA Holdings Inc | 25.28 | +63.40% |
| A | Agilent Technologies Inc | 26.96 | +74.23% |
| TMO | Thermo Fisher Scientific Inc | 31.53 | +103.77% |
| MTD | Mettler-Toledo International Inc | 32.45 | +109.73% |
| MEDP | Medpace Holdings Inc | 32.55 | +110.37% |
| DHR | Danaher Corp | 38.55 | +149.17% |
| IDXX | Idexx Laboratories Inc | 40.58 | +162.24% |
| ILMN | Illumina Inc | 44.12 | +185.14% |
| RVTY | Revvity Inc | 52.68 | +240.48% |
| VCYT | Veracyte Inc | 53.71 | +247.14% |
| ICLR | Icon Plc | 57.45 | +271.31% |
| SHC | Sotera Health Company | 74.08 | +378.81% |
| WAT | Waters Corp | 102.79 | +564.30% |